z-logo
open-access-imgOpen Access
Prospective follow-up of 838 fetuses conceived after ovarian stimulation with corifollitropin alfa: comparative and overall neonatal outcome
Author(s) -
M Bonduelle,
Bernadette Mannaerts,
Arthur Leader,
C Bergh,
D. Passier,
Paul Devroey
Publication year - 2012
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/des156
Subject(s) - medicine , live birth , embryo transfer , pregnancy , obstetrics , randomized controlled trial , incidence (geometry) , fetus , gynecology , surgery , genetics , physics , optics , biology
Is treatment with corifollitropin alfa, a new recombinant gonadotrophin with sustained follicle-stimulating activity, safe in terms of perinatal complications and birth defects in infants conceived following corifollitropin alfa treatment for contolled ovarian stimulation (COS)?

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom